Clinical and MRI Scale to Predict Very Poor Outcome in Tissue Plasminogen Activator Patients

Publisher： Karger

E-ISSN： 1421-9913|65|5|291-295

ISSN： 0014-3022

Source： European Neurology, Vol.65, Iss.5, 2011-04, pp. : 291-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Clinical-CT ‘Mismatch’ Predict Early Response to Treatment with Recombinant Tissue Plasminogen Activator?

By  

Cerebrovascular Diseases, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 384-388

Karger

Access to resources Recommend Favorite

Recanalization within One Hour after Intravenous Tissue Plasminogen Activator Is Associated with Favorable Outcome in Acute Stroke Patients

By  

European Neurology, Vol. 63, Iss. 6, 2010-06 ,pp. : 331-336

Karger

Access to resources Recommend Favorite

Effects of Uric Acid Levels on Outcome in Severe Ischemic Stroke Patients Treated with Intravenous Recombinant Tissue Plasminogen Activator

By  

European Neurology, Vol. 71, Iss. 3-4, 2013-12 ,pp. : 132-139

Karger

Access to resources Recommend Favorite

Validation of FLAIR Hyperintense Lesions as Imaging Biomarkers to Predict the Outcome of Acute Stroke after Intra-Arterial Thrombolysis following Intravenous Tissue Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 35, Iss. 5, 2013-05 ,pp. : 461-468

Karger

Access to resources Recommend Favorite

Safety and Efficacy of MRI-Based Selection for Recombinant Tissue Plasminogen Activator Treatment: Responder Analysis of Outcome in the 3-Hour Time Window

By  

Cerebrovascular Diseases, Vol. 27, Iss. 3, 2009-01 ,pp. : 223-229

Karger

Access to resources Recommend Favorite